Ginkgo Bioworks, a biotech company based in Boston, announced that it will go public via a merger with Soaring Eagle Acquisition Corp. (SRNG), a special purpose acquisition vehicle (SPAC), in a deal that gives the company a pre-money equity valuation of $15 billion. The company expects to receive ...

https://invezz.com/news/2021/05/11/ginkgo-bioworks-to-go-public-in-a-15b-spac-deal/

#InvezzNews